Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-044914
Filing Date
2024-11-12
Accepted
2024-11-12 19:38:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 160516
  Complete submission text file 0001493152-24-044914.txt   162352
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80470 | Film No.: 241450665
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 460 PARK AVENUE 22ND FLOOR NEW YORK NY 10022
Business Address 460 PARK AVENUE 22ND FLOOR NEW YORK NY 10022 646-942-5700
DG Capital Management, LLC (Filed by) CIK: 0001512716 (see all company filings)

EIN.: 208404862 | Fiscal Year End: 1231
Type: SC 13G/A